WC
NUTX

Winmill & Co’s Nutex Health NUTX Stock Holding History

Winmill & Co’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.21M Buy
+65,350
New +$8.01M 1.79% 18

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Winmill & Co's NUTX Position: Q1 2026 in Review

Winmill & Co opened a new position in Nutex Health (NUTX) in Q1 2026: 65,350 shares worth $6.21M. The stake represents 1.79% of the portfolio and ranks #18 among its holdings.

129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Winmill & Co held 65,350 shares of Nutex Health worth $6.21M as of Q1 2026.
  • Nutex Health was a new Winmill & Co position in Q1 2026.
  • Nutex Health made up 1.79% of Winmill & Co's portfolio in Q1 2026, its #18 holding.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Winmill & Co's 13F filing for Q1 2026, filed 14 May 2026.